Frontlight ResearchEarly access
Trial site
Salamanca
- 7running trials
- 4closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Familial hypercholesterolaemia3 trials
- Chronic myeloid leukaemia2 trials
- Coronary artery disease2 trials
- Myelodysplastic syndromes2 trials
- Myeloproliferative neoplasms2 trials
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Dermatomyositis and polymyositis (myositis)1 trial
- Metastatic breast cancer1 trial
- Multiple sclerosis1 trial
- Stroke1 trial
- Thalassaemia1 trial
- Phase
- Phase 35 trials
- Phase 22 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 41 trial
- Status
- Active, not recruiting6 trials
- Terminated3 trials
- Completed1 trial
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals11 trials
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis1 recruiting
Closed trials
Terminated
Phase Ib Study of Select Drug Combinations in Patients With Lower Risk MDS
Terminated
Terminated
Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026